a-galactosidase-treated pea-based crackers in patients with FGIDs. Effect of a-galacto-oligosaccharide removal on symptom severity in patients with functional gastrointestinal disorders
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
In patients with IBS or functional bloating the a-galactosidase treated cracker had no effect on gastrointestinal symptoms, breath hydrogen concentrations or the overall gut microbiota. ClinicalTrials.gov, number NCT05118243.
创建时间：
2023-03-07
